vs
Designer Brands Inc.（DBI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Designer Brands Inc.的季度营收约是Royalty Pharma plc的1.2倍（$752.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 2.4%，领先32.0%），Royalty Pharma plc同比增速更快（4.8% vs -3.2%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -0.1%）
Designer Brands Inc.是一家美国鞋履及时尚配饰零售商，主打销售设计师品牌与知名品牌商品，旗下拥有知名连锁零售品牌DSW（设计师鞋履仓库），目前在美国经营超过500家线下门店，同时运营线上电商平台。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DBI vs RPRX — 直观对比
营收规模更大
DBI
是对方的1.2倍
$622.0M
营收增速更快
RPRX
高出8.0%
-3.2%
净利率更高
RPRX
高出32.0%
2.4%
两年增速更快
RPRX
近两年复合增速
-0.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $752.4M | $622.0M |
| 净利润 | $18.2M | $214.2M |
| 毛利率 | 45.1% | — |
| 营业利润率 | 5.7% | 62.4% |
| 净利率 | 2.4% | 34.4% |
| 营收同比 | -3.2% | 4.8% |
| 净利润同比 | 40.0% | 2.9% |
| 每股收益（稀释后） | $0.35 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DBIRPRX
| Q4 25 | $752.4M | $622.0M | ||
| Q3 25 | $739.8M | $609.3M | ||
| Q2 25 | $686.9M | $578.7M | ||
| Q1 25 | $713.6M | $568.2M | ||
| Q4 24 | $777.2M | $593.6M | ||
| Q3 24 | $771.9M | $564.7M | ||
| Q2 24 | $746.6M | $537.3M | ||
| Q1 24 | $754.3M | $568.0M |
净利润DBIRPRX
| Q4 25 | $18.2M | $214.2M | ||
| Q3 25 | $10.8M | $288.2M | ||
| Q2 25 | $-17.4M | $30.2M | ||
| Q1 25 | $-38.2M | $238.3M | ||
| Q4 24 | $13.0M | $208.2M | ||
| Q3 24 | $13.8M | $544.0M | ||
| Q2 24 | $783.0K | $102.0M | ||
| Q1 24 | $-29.6M | $4.8M |
毛利率DBIRPRX
| Q4 25 | 45.1% | — | ||
| Q3 25 | 43.7% | — | ||
| Q2 25 | 43.0% | — | ||
| Q1 25 | 75.7% | — | ||
| Q4 24 | 43.0% | — | ||
| Q3 24 | 44.0% | — | ||
| Q2 24 | 44.2% | — | ||
| Q1 24 | 38.8% | — |
营业利润率DBIRPRX
| Q4 25 | 5.7% | 62.4% | ||
| Q3 25 | 3.6% | 70.1% | ||
| Q2 25 | -1.1% | 36.3% | ||
| Q1 25 | -3.6% | 94.0% | ||
| Q4 24 | 2.9% | 60.9% | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 1.3% | 50.2% | ||
| Q1 24 | -4.8% | -13.0% |
净利率DBIRPRX
| Q4 25 | 2.4% | 34.4% | ||
| Q3 25 | 1.5% | 47.3% | ||
| Q2 25 | -2.5% | 5.2% | ||
| Q1 25 | -5.3% | 41.9% | ||
| Q4 24 | 1.7% | 35.1% | ||
| Q3 24 | 1.8% | 96.3% | ||
| Q2 24 | 0.1% | 19.0% | ||
| Q1 24 | -3.9% | 0.8% |
每股收益（稀释后）DBIRPRX
| Q4 25 | $0.35 | $0.49 | ||
| Q3 25 | $0.22 | $0.67 | ||
| Q2 25 | $-0.36 | $0.07 | ||
| Q1 25 | $-0.69 | $0.55 | ||
| Q4 24 | $0.24 | $0.46 | ||
| Q3 24 | $0.24 | $1.21 | ||
| Q2 24 | $0.01 | $0.23 | ||
| Q1 24 | $-899.54 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.4M | $618.7M |
| 总债务越低越好 | $463.1M | $9.0B |
| 股东权益账面价值 | $298.6M | $9.7B |
| 总资产 | $2.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.55× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资DBIRPRX
| Q4 25 | $51.4M | $618.7M | ||
| Q3 25 | $44.9M | $938.9M | ||
| Q2 25 | $46.0M | $631.9M | ||
| Q1 25 | $44.8M | $1.1B | ||
| Q4 24 | $36.2M | $929.0M | ||
| Q3 24 | $38.8M | $950.1M | ||
| Q2 24 | $43.4M | $1.8B | ||
| Q1 24 | $49.2M | $843.0M |
总债务DBIRPRX
| Q4 25 | $463.1M | $9.0B | ||
| Q3 25 | $509.6M | $8.9B | ||
| Q2 25 | $516.2M | $8.0B | ||
| Q1 25 | $484.3M | $7.6B | ||
| Q4 24 | $529.6M | $7.6B | ||
| Q3 24 | $459.0M | $7.6B | ||
| Q2 24 | $469.3M | $7.6B | ||
| Q1 24 | $420.3M | $6.1B |
股东权益DBIRPRX
| Q4 25 | $298.6M | $9.7B | ||
| Q3 25 | $280.8M | $9.6B | ||
| Q2 25 | $266.9M | $9.5B | ||
| Q1 25 | $278.5M | $9.8B | ||
| Q4 24 | $318.5M | $10.3B | ||
| Q3 24 | $355.5M | $10.3B | ||
| Q2 24 | $358.5M | $9.8B | ||
| Q1 24 | $359.2M | $9.9B |
总资产DBIRPRX
| Q4 25 | $2.1B | $19.6B | ||
| Q3 25 | $2.1B | $19.3B | ||
| Q2 25 | $2.1B | $18.3B | ||
| Q1 25 | $2.0B | $17.6B | ||
| Q4 24 | $2.1B | $18.2B | ||
| Q3 24 | $2.1B | $18.0B | ||
| Q2 24 | $2.2B | $17.7B | ||
| Q1 24 | $2.1B | $16.1B |
负债/权益比DBIRPRX
| Q4 25 | 1.55× | 0.92× | ||
| Q3 25 | 1.81× | 0.93× | ||
| Q2 25 | 1.93× | 0.84× | ||
| Q1 25 | 1.74× | 0.78× | ||
| Q4 24 | 1.66× | 0.74× | ||
| Q3 24 | 1.29× | 0.74× | ||
| Q2 24 | 1.31× | 0.78× | ||
| Q1 24 | 1.17× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $66.5M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $57.5M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | 3.65× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $99.9M | — |
8季度趋势，按日历期对齐
经营现金流DBIRPRX
| Q4 25 | $66.5M | $827.1M | ||
| Q3 25 | $21.4M | $702.6M | ||
| Q2 25 | $-20.4M | $364.0M | ||
| Q1 25 | $70.1M | $596.1M | ||
| Q4 24 | $-9.8M | $742.5M | ||
| Q3 24 | $41.6M | $703.6M | ||
| Q2 24 | $-19.7M | $658.2M | ||
| Q1 24 | $-40.1M | $664.6M |
自由现金流DBIRPRX
| Q4 25 | $57.5M | — | ||
| Q3 25 | $11.9M | — | ||
| Q2 25 | $-27.6M | — | ||
| Q1 25 | $58.1M | — | ||
| Q4 24 | $-19.2M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $-35.6M | — | ||
| Q1 24 | $-52.8M | — |
自由现金流率DBIRPRX
| Q4 25 | 7.6% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | -2.5% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | -4.8% | — | ||
| Q1 24 | -7.0% | — |
资本支出强度DBIRPRX
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 1.7% | — |
现金转化率DBIRPRX
| Q4 25 | 3.65× | 3.86× | ||
| Q3 25 | 1.98× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -0.75× | 3.57× | ||
| Q3 24 | 3.01× | 1.29× | ||
| Q2 24 | -25.13× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DBI
| Womens | $280.7M | 37% |
| Athletic Footwear | $188.6M | 25% |
| Wholesale | $89.8M | 12% |
| Canada Retail Segment | $77.3M | 10% |
| Mens | $76.1M | 10% |
| Kids | $24.2M | 3% |
| Commission Income | $10.8M | 1% |
| Directto Consumer | $1.3M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
